课题基金 / 基金详情

G protein-gated K+ channels and inhibitory signaling

G protein-gated K+ channels and inhibitory signaling
G 蛋白门控 K 通道和抑制信号传导
批准号:
7340499
负责人:
KEVIN D WICKMAN
金额:
$27.97万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-04-01 至 2011-12-31

项目摘要

项目成果

KEVIN D WICKMAN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):神经元G蛋白门控的内向纠偏K+ (GIRK)通道介导许多神经递质和相关药物滥用的突触后抑制作用。我研究的长期目标是了解GIRK通道如何塑造与特定神经递质信号通路相关的行为。为了实现这一目标,我们需要了解原生GIRK通道多样性的功能含义,并且我们需要开发具有分子精度的干扰GIRK通道的方法。因此,本提案的目标是确定亚基组成如何影响GIRK通道和相关信号分子之间的相互作用。我们的工作假设是,亚基组成决定了GIRK通道和神经元蛋白之间的相互作用,促进了与适当的G蛋白偶联受体的偶联。这一假设将通过细胞生物学、生物化学、电生理学和行为实验来验证,这些实验将检验GIRK通道和GABAB受体之间的强大耦合。我们将利用一组强大的小鼠敲除系和定制衍生抗体的存在来鉴定促进含有girk2通道和GABAB受体之间强大功能相互作用的结构元件(AIM #1),以确定GIRK通道亚基组成如何影响与内源性神经元蛋白的相互作用(AIM #2)。并研究亚基组成如何影响GIRK通道对GABAB受体激活的行为效应的贡献(AIM #3)。在解决标准重组方法难以解决的与GIRK通道和G蛋白信号传导相关的问题的同时,拟议的研究还将为涉及GABAB受体和/或GIRK通道的信号传导的选择性扰动提出新的干预点。在gabab依赖信号的背景下,这一进展可能转化为治疗癫痫、疼痛和成瘾的新疗法。与公共卫生有关。所有用于治疗人类疾病或痛苦的药物都会产生有益和有害的效果。本研究的前提是,如果我们更好地理解药物给药后复杂生理和行为反应的分子机制,许多药物的有益作用可以被强调,或者负面作用可以被抑制。
英文摘要
DESCRIPTION (provided by applicant): Neuronal G protein-gated inwardly rectifying K+ (GIRK) channels mediate the postsynaptic inhibitory effect of many neurotransmitters and related drugs of abuse. The long-term goal of my research is to understand how GIRK channels shape behaviors associated with specific neurotransmitter signaling pathways. To accomplish this objective, we need to understand the functional implications of native GIRK channel diversity, and we need to develop the means to perturb GIRK channels with molecular precision. Accordingly, the goal of this proposal is to determine how subunit composition influences interactions between GIRK channels and related signaling molecules. Our working hypothesis is that subunit composition dictates interactions between GIRK channels and neuronal proteins that facilitate coupling with appropriate G protein-coupled receptors. The working hypothesis will be tested with cell biological, biochemical, electrophysiological, and behavioral experiments that examine the robust coupling between GIRK channels and the GABAB receptor. We will exploit the existence of a powerful set of mouse knockout lines and custom-derived antibodies to identify structural elements promoting robust functional interactions between GIRK2-containing channels and GABAB receptors (AIM #1), to determine how GIRK channel subunit composition influences interactions with endogenous neuronal proteins (AIM #2), and to examine how subunit composition influences the contribution of GIRK channels to the behavioral effects of GABAB receptor activation (AIM #3). While addressing issues related to GIRK channels and G protein signaling that have been refractory to standard recombinant approaches, the proposed research will also suggest novel points of intervention for the selective perturbation of signaling involving GABAB receptors and/or GIRK channels. In the context of GABAB-dependent signaling, such progress could translate into novel therapies for the treatment of epilepsy, pain, and addiction. Relevance to public health. All drugs used to treat human disease or distress produce both beneficial and untoward effects. The premise of the work presented in this application is that the beneficial effects of many drugs could be emphasized, or the negative effects suppressed, if we understood better the molecular mechanisms underlying the complex physiological and behavioral responses to drug administration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Alcohol-related suppression of GIRK channel activity in the basal amygdala: a link to plasticity of glutamatergic neurotransmission and withdrawal-associated behavior?
  • 批准号:
    10554284
  • 项目类别:
  • 资助金额:
    $34.0万
  • 财政年份:
    2020
  • 负责人:
    KEVIN D WICKMAN
  • 依托单位:
Alcohol-related suppression of GIRK channel activity in the basal amygdala: a link to plasticity of glutamatergic neurotransmission and withdrawal-associated behavior?
  • 批准号:
    10330020
  • 项目类别:
  • 资助金额:
    $34.0万
  • 财政年份:
    2020
  • 负责人:
    KEVIN D WICKMAN
  • 依托单位:
Viral Innovation Core
  • 批准号:
    10634615
  • 项目类别:
  • 资助金额:
    $42.67万
  • 财政年份:
    2020
  • 负责人:
    KEVIN D WICKMAN
  • 依托单位:
Viral Innovation Core
  • 批准号:
    10413184
  • 项目类别:
  • 资助金额:
    $42.76万
  • 财政年份:
    2020
  • 负责人:
    KEVIN D WICKMAN
  • 依托单位:
海外基金